Allergic bronchopulmonary aspergillosis in asthma: Epidemiological, clinical and therapeutic issues

Future Microbiology

Volumn 8, Issue 11, 2013, Pages 1463-1474

  Agarwal, Ritesh ^a   Chakrabarti, Arunaloke ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

ABPA; allergic bronchopulmonary aspergillosis; allergic bronchopulmonary mycosis; aspergillosis; Aspergillus; asthma; azoles

Indexed keywords

AMPHOTERICIN B; BUDESONIDE; FLUTICASONE; GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; ITRACONAZOLE; METHYLPREDNISOLONE; OMALIZUMAB; PLACEBO; POSACONAZOLE; PRECIPITIN; PREDNISOLONE; PYRROLE DERIVATIVE; STEROID; VORICONAZOLE;

ADRENAL INSUFFICIENCY; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBODY BLOOD LEVEL; ASPERGILLOMA; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; CUSHINGOID SYNDROME; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EOSINOPHILIA; FOLLOW UP; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INCIDENCE; INTENSIVE CARE UNIT; LOW DRUG DOSE; LUNG FUNCTION; LUNG FUNCTION TEST; OUTCOME ASSESSMENT; PATIENT MONITORING; PLEURA THICKENING; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REMISSION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN TEST; SPIROMETRY; THORAX RADIOGRAPHY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ASTHMA; GLUCOCORTICOIDS; HUMANS;

EID: 84888257090     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.116     Document Type: Review

References (121)

1. Agarwal R, Chakrabarti A. Epidemiology of allergic bronchopulmonary aspergillosis. In: Aspergillosis: From Diagnosis to Prevention, Pasqualotto AC (Ed.). Springer, NY, USA, 671-688 (2010).
2. Agarwal R. Allergic Bronchopulmonary Aspergillosis. In: Textbook of Pulmonary and Critical Care Medicine. Jindal SK, Shankar PS, Raoof S, Gupta D, Aggarwal AN, Agarwal R (Eds). Jaypee Publications, New Delhi, India, 947-970 (2010).
3. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 135(3), 805-826 (2009).
4. Hinson KF, Moon AJ, Plummer NS Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax 7(4), 317-333 (1952).
5. Imbeau SA, Cohen M, Reed CE Allergic bronchopulmonary aspergillosis in infants. Am. J. Dis. Child. 131(10), 1127-1130 (1977).
6. Kirsten D, Nowak D, Rabe K.F., Magnussen H. [Diagnosis of bronchopulmonary aspergillosis is often made too late]. Med. Klin. (Munich) 88(6), 353-356 (1993).
7. Agarwal R, Chakrabarti A. Clinical manifestations and natural history of allergic bronchopulmonary aspergillosis. In: Aspergillosis: From Diagnosis to Prevention, Pasqualotto AC (Ed.). Springer, NY, USA, 707-724 (2010).
8. Al-Mobeireek A.F., El-Rab M, Al-Hedaithy SS, Alasali K, Al-Majed S, Joharjy I. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir. Med. 95(5), 341-347 (2001). (Pubitemid 32624478)
9. Chakrabarti A, Sethi S, Raman D.S., Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 45(8), 295-299 (2002). (Pubitemid 35279060)
10. Agarwal R, Gupta D, Aggarwal A.N., Behera D., Jindal SK Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 130(2), 442-448 (2006). (Pubitemid 44267011)
11. Agarwal R, Gupta D, Aggarwal A.N., Saxena AK, Chakrabarti A, Jindal SK Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an ana lysis of 155 patients. Chest 132(4), 1183-1190 (2007). (Pubitemid 47620991)
12. Agarwal R, Chakarbarti A, Shah A et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin. Exp. Allergy 43(8), 850-873 (2013).
13. Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med. Mycol. 49(Suppl. 1), S150-S157 (2011).
14. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM The link between fungi and severe asthma: a summary of the evidence. Eur. Respir. J. 27(3), 615-626 (2006). (Pubitemid 43372538)
15. Agarwal R. Severe asthma with fungal sensitization. Curr. Allergy Asthma Rep. 11(5), 403-413 (2011).
16. Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am. J. Respir. Crit. Care Med. 179(1), 11-18 (2009).
17. Agarwal R. Allergic bronchopulmonary aspergillosis: lessons learnt from genetics. Indian J. Chest Dis. Allied Sci. 53(3), 137-140 (2011).
18. Kramer MN, Kurup V P, Fink JN Allergic bronchopulmonary aspergillosis from a contaminated dump site. Am. Rev. Respir. Dis. 140(4), 1086-1088 (1989). (Pubitemid 19259517)
19. Coughlan CA, Chotirmall SH, Renwick J et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am. J. Respir. Crit. Care Med. 186(10), 999-1007 (2012).
20. Agarwal R, Garg M, Aggarwal A.N., Saikia B., Gupta D, Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir. Med. 106(7), 942-947 (2012).
21. Chowdhary A, Agarwal K, Kathuria S., Gaur SN, Randhawa HS, Meis JF Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit. Rev. Microbiol. doi:10.3109/1040841X.754401 (2013) (Epub ahead of print).
22. Gergen PJ, Arbes SJ Jr, Calatroni A, Mitchell HE, Zeldin DC Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006. J. Allergy Clin. Immunol. 124(3), 447-453 (2009).
23. Agarwal R, Aggarwal AN, Gupta D, Jindal SK Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 13(8), 936-944 (2009).
24. Benatar SR, Keen GA, Du Toit Naude W. Aspergillus hypersensitivity in asthmatics in Cape Town. Clin. Allergy 10(3), 285-291 (1980). (Pubitemid 10071317)
25. Donnelly SC, Mclaughlin H, Bredin CP Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-1988. Ir. J. Med. Sci. 160(9), 288-290 (1991).
26. Novey HS. Epidemiology of allergic bronchopulmonary aspergillosis. Immunol. Allergy Clin. North Am. 18(3), 641-653 (1998). (Pubitemid 28369712)
27. Eaton T, Garrett J, Milne D., Frankel A, Wells AU Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 118(1), 66-72 (2000). (Pubitemid 30485491)
28. Ma YL, Zhang WB, Yu B, Chen Y.W., Mu S., Cui YL [Prevalence of allergic bronchopulmonary aspergillosis in Chinese patients with bronchial asthma]. Zhonghua Jie He He Hu Xi Za Zhi 34(12), 909-913 (2011).
29. Agarwal R, Nath A, Aggarwal A.N., Gupta D., Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in north India. Mycoses 53(2), 138-143 (2010).
30. Denning DW, Pleuvry A, Cole DC Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med. Mycol. 51(4), 361-370 (2013).
31. Chakrabarti A, Agarwal R, Cole D.C., Pleuvry A., Denning DW Estimation of the burden of chronic and allergic aspergillosis in India. Presented at: ESCMID-ECCMID. Berlin, Germany, 27-30 April 2013 (Poster 1045).
32. Agarwal R, Maskey D, Aggarwal AN et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS ONE 8(4), e61105 (2013).
33. Bousquet J, Anto JM, Bachert C et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 61(6), 671-680 (2006). (Pubitemid 43801400)
34. Patterson R, Fink JN, Pruzansky JJ et al. Serum immunoglobulin levels in pulmonary allergic aspergillosis and certain other lung diseases, with special reference to immunoglobulin E. Am. J. Med. 54(1), 16-22 (1973).
35. Wang JL, Patterson R, Rosenberg M., Roberts M, Cooper BJ Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am. Rev. Respir. Dis. 117(5), 917-927 (1978). (Pubitemid 8329099)
36. Baxter CG, Dunn G, Jones AM et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J. Allergy Clin. Immunol. 132(3),560-566 (2013).
37. Marchant JL, Warner JO, Bush A. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 49(10), 1002-1005 (1994). (Pubitemid 24315993)
38. Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 74(1), 68-71 (1984). (Pubitemid 14093028)
39. Agarwal R, Gupta D, Aggarwal AN et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir. Med. 104(2), 204-210 (2010).
40. Campbell MJ, Clayton YM Bronchopulmonary aspergillosis. A correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis. Am. Rev. Respir. Dis. 89, 186-196 (1964).
41. McCarthy DS, Pepys S. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 1. Clinical features. Clin. Allergy 1(1), 261-286 (1971).
42. McCarthy DS, Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin. Allergy 1(4), 415-432 (1971).
43. Longbottom JL, Pepys J. Pulmonary aspergillosis: diagnostic and immunological significance of antigens and C-substance in Aspergillus Fumigatus. J. Pathol. Bacteriol. 88, 141-151 (1964).
44. Baxter CG, Denning DW, Jones A.M., Todd A., Moore CB, Richardson MD Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin. Microbiol. Infect. 19(4), e197-e204 (2013).
45. Agarwal R, Khan A, Aggarwal AN et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis. J. Infect. Public Health 4(5-6), 235-243 (2011).
46. Agarwal R, Noel V, Aggarwal A.N., Gupta D., Chakrabarti A. Clinical significance of Aspergillus sensitisation in bronchial asthma. Mycoses 54(5), e531-e538 (2011).
47. Pashley CH, Fairs A, Morley JP et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med. Mycol. 50(4), 433-438 (2012).
48. Denning DW, Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52 (9), 1123-1129 (2011).
49. Kurup VP, Banerjee B, Hemmann S., Greenberger PA, Blaser K, Crameri R. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin. Exp. Allergy 30(7), 988-993 (2000). (Pubitemid 30427040)
50. Crameri R, Hemmann S, Ismail C., Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int. Immunol. 10(8), 1211-1216 (1998). (Pubitemid 28362696)
51. Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int. Arch. Allergy Immunol. 115 (2), 99-114 (1998). (Pubitemid 28048339)
52. Crameri R, Lidholm J, Gronlund H., Stuber D, Blaser K, Menz G. Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia Cap System. Clin. Exp. Allergy 26(12), 1411-1419 (1996). (Pubitemid 27019797)
53. Bowyer P, Blightman O, Denning DW Relative reactivity of Aspergillus allergens used in serological tests. Med. Mycol. 44(Suppl. 1), 23-28 (2006). (Pubitemid 44524081)
54. Agarwal R, Khan A, Garg M., Aggarwal AN, Gupta D. Pictorial essay: allergic bronchopulmonary aspergillosis. Indian J. Radiol. Imaging 21(4), 242-252 (2011).
55. Lynch DA. Imaging of asthma and allergic bronchopulmonary mycosis. Radiol. Clin. North Am. 36(1), 129-142 (1998). (Pubitemid 28079679)
56. Panchal N, Bhagat R, Pant C., Shah A. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir. Med. 91(4), 213-219 (1997). (Pubitemid 27168366)
57. Hansell DM, Strickland B. High-resolution computed tomography in pulmonary cystic fibrosis. Br. J. Radiol. 62(733), 1-5 (1989). (Pubitemid 19026911)
58. Agarwal R, Khan A, Garg M., Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J. Radiol. 4(4), 141-150 (2012).
59. Reiff DB, Wells AU, Carr D.H., Cole PJ, Hansell DM CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. AJR Am. J. Roentgenol. 165(2), 261-267 (1995).
60. Agarwal R. High attenuation mucoid impaction in allergic bronchopulmonary aspergillosis. World J. Radiol. 2(1), 41-43 (2010).
61. Goyal R, White CS, Templeton P.A., Britt EJ, Rubin LJ High attenuation mucous plugs in allergic bronchopulmonary aspergillosis: CT appearance. J. Comput. Assist. Tomogr. 16(4), 649-650 (1992).
62. Logan PM, Muller NL High-attenuation mucous plugging in allergic bronchopulmonary aspergillosis. Can. Assoc. Radiol. J. 47(5), 374-377 (1996). (Pubitemid 26379563)
63. Agarwal R, Aggarwal AN, Gupta D. High-attenuation mucus in allergic bronchopulmonary aspergillosis: another cause of diffuse high-attenuation pulmonary abnormality. AJR Am. J. Roentgenol. 186(3), 904 (2006). (Pubitemid 46100288)
64. Smith NL, Denning DW Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur. Respir. J. 37(4), 865-872 (2011).
65. Rosenberg M, Patterson R, Mintzer R., Cooper BJ, Roberts M, Harris KE Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann. Intern. Med. 86(4), 405-414 (1977). (Pubitemid 8078948)
66. Patterson R, Greenberger PA, Halwig J.M., Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch. Intern. Med. 146(5), 916-918 (1986). (Pubitemid 16116672)
67. Agarwal R. Controversies in allergic bronchopulmonary aspergillosis. Int. J. Respir. Care 6(2), 53-54, 56-63 (2010).
68. Agarwal R, Hazarika B, Gupta D., Aggarwal AN, Chakrabarti A, Jindal SK Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med. Mycol. 48(7), 988-994 (2010).
69. Patterson R, Greenberger PA, Radin R.C., Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann. Intern. Med. 96(3), 286-291 (1982). (Pubitemid 12187503)
70. Agarwal R, Khan A, Gupta D., Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS ONE 5(12), e15346 (2010).
71. Agarwal R, Aggarwal AN, Garg M, Saikia B., Gupta D, Chakrabarti A. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome. Mycopathologia 174(3), 193-201 (2012).
72. Halwig JM, Greenberger PA, Levine M, Patterson R. Recurrence of allergic bronchopulmonary aspergillosis after seven years of remission. J. Allergy Clin. Immunol. 74(5), 738-740 (1984). (Pubitemid 15211000)
73. Lee TM, Greenberger PA, Patterson R, Roberts M., Liotta JL Stage V (fibrotic) allergic bronchopulmonary aspergillosis. A review of 17 cases followed from diagnosis. Arch. Intern. Med. 147(2), 319-323 (1987). (Pubitemid 17040254)
74. Baur X, Weiss W, Jarosch B et al. Immunoprint pattern in patients with allergic bronchopulmonary aspergillosis in different stages. J. Allergy Clin. Immunol. 83(4), 839-844 (1989). (Pubitemid 19127953)
75. Greenberger PA, Miller TP, Roberts M, Smith LL Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann. Allergy 70(4), 333-338 (1993). (Pubitemid 23110029)
76. Kumar R. Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation. Chest 124(3), 890-892 (2003). (Pubitemid 37123305)
77. Agarwal R. What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. Expert Rev. Respir. Med. 6(4), 363-371 (2012).
78. Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React. Toxicol. Rev. 15(4), 203-206 (1996). (Pubitemid 27156338)
79. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 96(1), 23-43 (2002). (Pubitemid 35346616)
80. Denning DW, Van Wye JE, Lewiston NJ, Stevens DA Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 100(3), 813-819 (1991).
81. Stevens DA, Schwartz HJ, Lee JY et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N. Engl. J. Med. 342(11), 756-762 (2000). (Pubitemid 30151919)
82. Wark PA, Hensley MJ, Saltos N et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J. Allergy Clin. Immunol. 111(5), 952-957 (2003). (Pubitemid 36570853)
83. Nepomuceno IB, Esrig S, Moss RB Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 115(2), 364-370 (1999). (Pubitemid 29083042)
84. Hilton AM, Chatterjee SS Bronchopulmonary aspergillosis - treatment with beclomethasone dipropionate. Postgrad. Med. J. 51(Suppl. 4), 98-103 (1975).
85. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Report to the Research Committee of the British Thoracic Association. Br. J. Dis. Chest 73(4), 349-356 (1979).
86. Heinig JH, Weeke ER, Groth S, Schwartz B. High-dose local steroid treatment in bronchopulmonary aspergillosis. A pilot study. Allergy 43(1), 24-31 (1988). (Pubitemid 18058170)
87. Balter MS, Rebuck AS Treatment of allergic bronchopulmonary aspergillosis with inhaled corticosteroids. Respir. Med. 86(5), 441-442 (1992).
88. Imbeault B, Cormier Y. Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest 103(5), 1614-1617 (1993). (Pubitemid 23145638)
89. Seaton A, Seaton RA, Wightman AJ Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow-up. QJM 87(9), 529-537 (1994). (Pubitemid 24289823)
90. Agarwal R, Khan A, Aggarwal A.N., Saikia B., Gupta D, Chakrabarti A. Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA). Intern. Med. 50(8), 855-860 (2011).
91. Laoudi Y, Paolini JB, Grimfed A, Just J. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Eur. Respir. J. 31(4), 908-909 (2008).
92. Hayes D Jr, Murphy B.S., Lynch JE, Feola DJ Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis. Pediatr. Pulmonol. 45 (11), 1145-1148 (2010).
93. Proesmans M, Vermeulen F, Vreys M., De Boeck K. Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Int. J. Pediatr. 2010, 376287 (2010).
94. Godet C, Meurice JC, Roblot F et al. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA. Eur. Respir. J. 39(5), 1261-1263 (2012).
95. van der Ent CK, Hoekstra H, Rijkers GT Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 62(3), 276-277 (2007). (Pubitemid 46579813)
96. Zirbes JM, Milla CE Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr. Pulmonol. 43(6), 607-610 (2008). (Pubitemid 351813015)
97. Alcorta A. Successful treatment of allergic bronchopulmonary aspergillosis with omalizumab. Allergy 64, 477-478 (2009).
98. Brinkmann F, Schwerk N, Hansen G., Ballmann M. Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis. Allergy 65(1), 134-135 (2010).
99. Perez-De-Llano LA, Vennera MC, Parra A et al. Effects of omalizumab in Aspergillus-associated airway disease. Thorax 66(6), 539-540 (2011).
100. Tillie-Leblond I., Germaud P, Leroyer C et al. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy 66(9), 1254-1256 (2011).
101. Sastre I, Blanco J, Mata H., Garcia F. A case of allergic bronchopulmonary aspergillosis treated with omalizumab. J. Investig. Allergol. Clin. Immunol. 22(2), 145-147 (2012).
102. Wong R, Wong M, Robinson P.D., Fitzgerald DA Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis. Paediatr. Respir. Rev. 14(1), 22-24 (2013).
103. Thomson JM, Wesley A, Byrnes C.A., Nixon GM Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr. Pulmonol. 41(2), 164-170 (2006). (Pubitemid 43165446)
104. Cohen-Cymberknoh M., Blau H, Shoseyov D et al. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis. J. Cyst. Fibros. 8(4), 253-257 (2009).
105. Sehgal IS, Agarwal R. Pulse methylprednisolone in ABPA exacerbations: case-report and review of literature. Eur. Respir. Rev. (2013) (In Press).
106. Hilliard T, Edwards S, Buchdahl R et al. Voriconazole therapy in children with cystic fibrosis. J. Cyst. Fibros. 4(4), 215-220 (2005). (Pubitemid 43013027)
107. Mccallum BJ, Amrol D, Horvath J., Inayat N, Talwani R. A case of allergic bronchopulmonary aspergillosis leading to pneumonia with unusual organisms. South. Med. J. 98(11), 1135-1138 (2005). (Pubitemid 41780356)
108. Erwin GE, Fitzgerald JE Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole. J. Asthma 44(10), 891-895 (2007).
109. Glackin L, Leen G, Elnazir B., Greally P. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Ir. Med. J. 102(1), 29 (2009).
110. Chishimba L, Niven RM, Cooley J, Denning DW Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J. Asthma 49(4), 423-433 (2012).
111. Bolland MJ, Bagg W, Thomas M.G., Lucas JA, Ticehurst R, Black PN Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole. Ann. Pharmacother. 38(1), 46-49 (2004). (Pubitemid 38018004)
112. De Wachter E., Vanbesien J, De Schutter I, Malfroot A, De Schepper J. Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide. Eur. J. Pediatr. 162(7-8), 488-489 (2003). (Pubitemid 36904271)
113. Parmar JS, Howell T, Kelly J., Bilton D. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 57(8), 749-750 (2002). (Pubitemid 34864536)
114. Naef R, Schmid C, Hofer M., Minder S, Speich R, Boehler A. Itraconazole comedication increases systemic levels of inhaled fluticasone in lung transplant recipients. Respiration 74(4), 418-422 (2007). (Pubitemid 47093155)
115. Gilchrist FJ, Cox KJ, Rowe R et al. Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis. J. Cyst. Fibros. 12(4), 399-402 (2013).
116. Nair P, Pizzichini MM, Kjarsgaard M et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med. 360(10), 985-993 (2009).
117. Corren J, Lemanske RF, Hanania NA et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365(12), 1088-1098 (2011).
118. Greenberger PA. Allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 110(5), 685-692 (2002). (Pubitemid 35423169)
119. Vlahakis NE, Aksamit TR Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin. Proc. 76(9), 930-938 (2001). (Pubitemid 32825915)
120. Trial on the efficacy and safety of two different glucocorticoid dose regimens in allergic bronchopulmonary aspergillosis. http://clinicaltrials.gov/ show/NCT00974766
121. Monotherapy of itraconazole versus prednisolone in allergic bronchopulmonary aspergillosis (MIPA). http://clinicaltrials.gov/show/ NCT01321827